Provider delays among patients with breast cancer in a Regional Cancer Care Network: Feasibility of personal care schedule;Délais de prise en charge des patientes atteintes d'un cancer du sein dans un réseau régional de soins en cancérologie: Faisabilité d'un programme personnalisé de soins

Bulletin du Cancer

Volumn 91, Issue 12, 2004, Pages 965-971

  Latarche, Clotilde ^a   Desandes, Emmanuel ^a   Mayeux, Daniel ^a   Stines, Joseph ^a   Guillemin, François ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Breast cancer; Delays; Patient pathway

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PATHWAY; FEMALE; FRANCE; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; TIME; TREATMENT PLANNING;

ADULT; AGED; BREAST NEOPLASMS; CRITICAL PATHWAYS; FEASIBILITY STUDIES; FEMALE; FRANCE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MIDDLE AGED; TIME FACTORS;

EID: 12844259425     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 1993; 36: 1521-34.
2. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez N. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999; 353: 1119-26.
3. Coates AS. Breast: delays, dilemmas, and delusions. Lancet 1999; 353: 1112-3.
4. Sainsbury R, Johnston C, Haward B. Effect on survival of delays on patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999; 353: 1132-5.
5. Olivotto IA, Bancej C, Goel V, Snider J, Mc Auley RG, Irvine B, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadien provinces. CMAJ 2001; 165: 277-83.
6. Thorne SE, Harris SR, Hislop TG, Vestrup JA. The experience of waiting for diagnosis after an abnormal mammogram. Breast J 1999; 5: 42-51.
7. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multicentre follow-up study comparing different breast screening result group five months after their last breast screening appointment. J Public Health Med 1998; 20: 396-403.
8. Arndt V, Stüner T, Stegmaier C, Ziegler H, Becker A, Brenner H. Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 2003; 21: 1440-6.
9. Mayo NE, Scott SC, Shen N, Hanley J, Goldberg MS, MacDonald N. Waiting time for breast cancer surgery in Quebec. Waiting time for breast cancer surgery in Quebec. CMAJ 2001; 8: 1133-8.
10. Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey. BMJ 2000; 320: 838-9.
11. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994; 30: 221-8.
12. Robinson D, Bell CM, Moller H, Basnett I. Effect of UK government's 2-week target on waiting times in women with breast cancer in southeast England. Br J Cancer 2003; 89: 492-6.
13. Shannon C, Ashley S, Smith IE. Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol 2003; 21: 3792-7.
14. Colleoni M, Bonetti M, Coates A, Castiglione-Gertsch M, Gelber RD, Price K, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. J Clin Oncol 2000; 18: 584-90.
15. Benk V, Ho V, Fortin PR, Zhang G, Levinton C, Freeman CR. Predictors of delay in starting radiation treatment for patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1998; 41: 109-15.
16. Hebert-Croteau N, Freeman CR, Latreille J, Brisson J. Delay in adjuvant radiation treatment and outcomes of breast cancer: a review. Breast Cancer Res Treat 2002; 74: 77-94.
17. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Delaying post-operative radiotherapy may increase risk of local recurrence in people with breast cancer. J Clin Oncol 2003; 21: 555-63.
18. Mauriac L. Standards, Options et Recommandations: cancers du sein infiltrants non métastatiques. 2e édition, mise à jour, version abrégée. Bull Cancer 2002; 89: 207-24.